Quebec City vaccine candidate to treat new strain of influenza
A particularly lethal new influenza strain is raising the alarm in China. No human cases have been detected outside of the country, but that's not stopping researchers and scientists around the world from working on a new vaccine.
One new vaccine, a VLP (virus-like particle) has been developped here in Quebec City. Medicago is the biopharmaceutical company behind this and their president and CEO Andy Sheldon joins us now with more.